Hypoxia appears to promote contraction [hypoxic pulmonary vasoconstriction (HPV)] of bovine pulmonary arteries (BPA) through removal of a peroxide-mediated relaxation. This study examines the roles of BPA Nox oxidases and mitochondria in the HPV response. Inhibitors of Nox2 (0.1 mM apocynin and 50 M gp91-dstat) and mitochondrial electron transport (10 M antimycin and rotenone) decreased superoxide generation in BPA without affecting contraction to 25 mM KCl or the HPV response. Transfection of BPA with small inhibitory RNA (siRNA) for Nox2 and Nox4 decreased Nox2 and Nox4 protein expression, respectively, associated with an attenuation of superoxide detection, without affecting 25 mM KCl contraction. However, Nox4 siRNA, but not Nox2, attenuated HPV in BPA. A Nox4 inhibitor plumbagin (10 M) increased basal force, decreased superoxide detection and peroxide release, and caused BPA to relax under hypoxia. Although acute removal of peroxide with 0.1 mM ebselen increased 25 mM KCl contraction and decreased hypoxic contraction, prolonged treatment with ebselen only decreased hypoxic contraction without affecting 25 mM KCl contraction, suggesting basal peroxide levels also maintain a contractile mechanism not removed by acute hypoxia. Organ culture of BPA with transforming growth factor (TGF)-␤1 (4 nM) increased Nox4 expression, superoxide, peroxide, and the HPV response. Thus Nox2 and mitochondria are sources for superoxide generation in BPA, which do not appear to influence the HPV response. However, peroxide derived from superoxide generated by Nox4 appears to maintain a basal relaxation in BPA under normoxic conditions, which is removed under hypoxia leading to HPV. Peroxide generated by Nox4 may also function to maintain a contractile mechanism, which is not reversed by acute hypoxia. hydrogen peroxide; hypoxic pulmonary vasoconstriction; mitochondria; Nox oxidase; oxygen sensor PULMONARY ARTERIES CONSTRICT when exposed to hypoxic conditions to divert blood away from poorly ventilated areas of the lungs to better ventilated areas to maintain a good ventilation perfusion ratio. This response is known as hypoxic pulmonary vasoconstriction (HPV), and it is the opposite of what is observed in the systemic circulation where arteries vasodilate in response to hypoxia to supply increased blood flow to hypoxic tissues. Various studies (14, 17, 26) have pointed toward reactive oxygen species (ROS) as being key mediators in HPV as a result of the initial proposal of the redox theory for HPV by Archer et al. (4). However, there is much controversy in the field (17-19, 25) on the source of ROS generation and whether hypoxia functions to increase or decrease ROS in pulmonary arterial smooth muscle cells. The two main candidates for the generation of ROS have been the mitochondrial electron transport chain and the Nox oxidases (2, 4, 14, 17, 19, 20, 21, 25, 26) . In addition, there is recent evidence for mitochondrial derived ROS activating Nox oxidases (24). Studies conducted by Archer et al. (3) in gp91phox (Nox2) knockout mice showed that the HPV response was not affected in these mice, indicating that Nox2 oxidase was not the primary source for the ROS involved in the response to hypoxia in pulmonary arteries. This, however, does not exclude the role of other Nox oxidases like Nox4 in the generation of ROS involved in HPV.
PULMONARY ARTERIES CONSTRICT when exposed to hypoxic conditions to divert blood away from poorly ventilated areas of the lungs to better ventilated areas to maintain a good ventilation perfusion ratio. This response is known as hypoxic pulmonary vasoconstriction (HPV), and it is the opposite of what is observed in the systemic circulation where arteries vasodilate in response to hypoxia to supply increased blood flow to hypoxic tissues. Various studies (14, 17, 26) have pointed toward reactive oxygen species (ROS) as being key mediators in HPV as a result of the initial proposal of the redox theory for HPV by Archer et al. (4) . However, there is much controversy in the field (17) (18) (19) 25) on the source of ROS generation and whether hypoxia functions to increase or decrease ROS in pulmonary arterial smooth muscle cells. The two main candidates for the generation of ROS have been the mitochondrial electron transport chain and the Nox oxidases (2, 4, 14, 17, 19, 20, 21, 25, 26) . In addition, there is recent evidence for mitochondrial derived ROS activating Nox oxidases (24) . Studies conducted by Archer et al. (3) in gp91phox (Nox2) knockout mice showed that the HPV response was not affected in these mice, indicating that Nox2 oxidase was not the primary source for the ROS involved in the response to hypoxia in pulmonary arteries. This, however, does not exclude the role of other Nox oxidases like Nox4 in the generation of ROS involved in HPV.
Previous studies from our laboratory in endothelium-removed bovine pulmonary arteries (BPA) detected evidence that hypoxia removes a basal peroxide-mediated relaxation maintained under normoxic conditions. This peroxide originates from superoxide generated by a cytosolic NAD(P)Hdependent Nox oxidase activity, which remains to be identified (1, 21) . A contributing factor to the HPV response in BPA appears to be removal of a cGMP relaxing mechanism associated with the metabolism of peroxide by catalase maintaining activation of soluble guanylate cyclase (6 -8) . Various studies by us and others (4, 7-9, 14, 19) show that during hypoxia superoxide production is decreased, leading to a decrease in peroxide levels and attenuation of a hypothesized basal relaxation causing HPV. This observation is further supported by a study from our laboratory (1) showing that scavenging peroxide in BPA with ebselen results in an increase in force development to KCl and an attenuation of HPV. Therefore, this study examines the role of Nox oxidases and mitochondria in the generation of ROS and their role in modulating the HPV response in BPA. Since our previous studies suggest that BPA appear to express Nox2 and Nox4, but do not show detectable levels of Nox1 by Western and RT-PCR analysis (14) , we focused on examining the role of these Nox oxidases in the HPV response.
MATERIALS AND METHODS

Materials.
Analyzed reagent grade salts from Baker Chemical were used for making all solutions, whereas other chemicals were obtained from Sigma Chemical (St. Louis, MO) unless mentioned. Doses for inhibitor were selected based on standard reported doses from previous studies, which showed effective inhibition of the target without influencing other systems controlling vascular function.
Tissue. Branches of BPA were isolated from calf lungs transported from a slaughter house in chilled physiological buffer solution. Firstand second-order branches of the main lobar pulmonary arteries were then cleaned off their connective tissue and de-endothelialized using a wooden stick to eliminate the influence of additional endotheliumdependent mechanisms in the response to hypoxia. Rings measuring 2 to 3 mm in width were made from the arteries and either directly used for vascular reactivity studies or organ cultured with either small inhibitory RNA (siRNA) or TGF-␤1. Arterial rings were organ cultured for 48 h, a condition selected to maximize alterations in Nox oxidase protein expression and minimize alterations in contractile function. When arteries were organ cultured for 48 h force generation to 30 mM KCl appeared to be decreased by about 30% compared with freshly dissected untreated tissue under the various conditions examined.
RNA interference of Nox2 and Nox4. siRNA sequences for inhibiting Nox2 and Nox4 were designed using the Qiagen siRNA design program, and they were synthesized and double stranded by Xeragon. The sequences used for silencing were AAGTCGGTCTGGTA-CAAATAT and AAGACCTGGCCAGTATATATTAT for Nox2 and Nox4, respectively. A scrambled RNA having the sequence AAT-TCTCCGAACGTGTCACGT was also designed by Qiagen to serve as a negative control. The transfection was conducted with 180 nM siRNA incubated for the first 24 h in Dulbecco's modified Eagle's medium (DMEM) only at 37°C with 5% carbon dioxide using the Qiagen transmessenger transfection reagent kit with a 1:1.5:1 ratio of enhancer R, siRNA, and transmessenger transfection reagent. Each ring was transfected in a separate well of a sterile 96 well plate with a final volume of 250 l of the transfection media. After 24 h the rings were moved to another plate containing DMEM with 10% fetal bovine serum and antibiotics (penicillin, streptomycin, fungizone) for a further 24 h at 37°C with 5% carbon dioxide.
TGF-␤1 organ culture. Another set of vessels was incubated in the presence and absence of 4 nM TGF-␤1 (T-7039; Sigma Aldrich) in DMEM with 10% fetal bovine serum and antibiotics (penicillin, streptomycin, fungizone) for 48 h at 37°C with 5% carbon dioxide.
Vascular reactivity. Freshly isolated and organ cultured rings described above were used for recording isometric force development using either Grass (FT-03) force displacement transducers attached to a Grass Instruments polygraph recorder or Coulborne Instruments force transducers, which were in turn attached to Powerlab data acquisition system from ADInstruments. Arterial rings were initially incubated at a passive tension of 5 g for 1 h in Krebs-bicarbonate buffer solution containing (in mM) 118 NaCl, 4.7 KCl, 1.5 CaCl 2, 25 NaHCO3, 1.1 MgSO4, 1.2 KH2PO4, and 5.6 glucose gassed with 21% O2-5% CO2-74% N2. The temperature was maintained at 37°C in the individually thermostated baths containing the rings. Following this 1 h of incubation the arterial rings were depolarized with 123 mM KCl containing Krebs-bicarbonate buffer, and the rings were again reequilibrated with normal Krebs-bicarbonate buffer for another 30 min. The BPA rings were then contracted with 30 mM KCl containing Krebs-bicarbonate solution and were then again re-equilibrated with normal Krebs-bicarbonate solution for 30 min. After this period some of the BPA rings were exposed to probes (0.1 mM ebselen, 100 M apocynin, 50 M gp91-dstat, 10 M antimycin, 10 M rotenone, and Fig. 1 . Effects of inhibition of Nox2 activation on the levels of bovine pulmonary arteries (BPA) superoxide. Superoxide generation detected by 5 M lucigenin chemiluminescence is decreased in the presence of 100 M apocynin and 50 M gp91-dstat (n ϭ 10 -12). Fig. 2 . Effects of inhibition of Nox2 activation on the contraction of BPA to 25 mM KCl and hypoxia. Force generation to 25 mM KCl is not affected in the presence of 100 M apocynin (n ϭ 6; A) and 50 M gp91-dstat (n ϭ 7; B). Hypoxic contraction is also not affected in the presence of apocynin (n ϭ 6; C) and gp91-dstat (n ϭ 7; D).
10 M indomethacin) for another 30 min. Plumbagin treatment (10 M) was done for 1 h instead of 30 min. For experiments requiring prolonged incubation of ebselen some of the rings were preincubated in the absence or presence of ebselen for 45 min before exposure to passive tension for vascular reactivity studies and ebselen was maintained in the tissue baths throughout the entire protocol. Since BPA need to be partially precontracted to observe an increase in force on exposure to hypoxia, arteries were then precontracted with either 20 or 25 mM KCl before being exposed to 20 min of hypoxia by changing the gassing in the baths from 21% O 2-5% CO2-74% N2 to 5% CO2-95% N2 (pO2, ϳ8 -10 torr). Finally, they were reoxygenated by changing the gas mixture to 21% O2-5% CO2-74% N2. Our previous studies provided evidence that organ culture or the concentration of KCl used to precontract BPA did not alter the role of peroxide in the response to hypoxia (1) . Data are reported as a percentage of the force generated by the initial contraction to 30 mM KCl, which generates ϳ60% of maximal force. Since most data in RESULTS are reported as the percentage of this contraction to 30 mM KCl, it was confirmed that the various organ culture treatments used did not alter the amount of force generated in grams on exposure to 30 mM KCl compared with controls.
Superoxide and peroxide measurement using chemiluminescence. Changes in superoxide were measured from quantifying the chemiluminescence of 5 M lucigenin in a liquid scintillation counter (LS6000IC; Beckman Instruments, San Diego, CA) with a single active photomultiplier tube in a dark room. Initial background chemiluminescence was measured in plastic scintillation minivials containing lucigenin and other drugs in 1 ml of Krebs solution buffered with 10 mM HEPES-NaOH (pH 7.4) in the absence of tissue. This measurement was subtracted from subsequent measurements made in the presence of BPA rings. Following this, rings from treated and untreated BPA were placed in the minivials to measure superoxide generation in the presence of the tissue. The tissue was weighed at the end of the experiment, and the counts were divided by weight to give the readings in counts per minute per gram of tissue. Our previous studies have provided evidence that lucigenin detects superoxide from intracellular sources including mitochondria in a manner that is markedly attenuated by superoxide scavengers (13) (14) (15) . Peroxide released from BPA was detected by substituting 10 M luminol and 1 nM horseradish peroxidase for lucigenin in the chemiluminescence methods used for superoxide. Data reported in RESULTS document that the chemiluminescence detected from BPA is essentially eliminated in the presence of 1 M catalase.
Western blot analysis. Western blot analysis was performed on rings flash frozen with liquid nitrogen immediately after experimental protocols described in RESULTS were conducted. The rings were placed in the lysis buffer containing 50 mM Tris·HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, and protease cocktail (Sigma Chemical) Fig. 4 . Effects of siRNA for Nox2 and Nox4 on the levels of superoxide in BPA and on the contraction of BPA to 25 mM KCl and hypoxia. A: superoxide levels detected 5 M lucigenin are decreased in both Nox2 and Nox4 siRNA (180 nM)-treated BPA, whereas scrambled siRNA (Scramb; 180 nM) did not have any effect (n ϭ 12). B: 25 mM KCl contraction is not affected by Nox4, Nox2, or scrambled siRNA (n ϭ 15). C: hypoxic contraction is only decreased in the presence of Nox4 siRNA, whereas Nox2 and scrambled siRNA have no effect (n ϭ 15). immediately after being pulverized in a mortar and pestle. The samples were then centrifuged, and the supernatant was collected for protein analysis by the modified Bradford method (5). The protein concentration of the supernatant was measured following this on a plate reader, and 70 g of protein were added from each sample and run on a 10% SDS-PAGE gel. The gel was then transferred onto a nitrocellulose membrane and subsequently exposed to the primary and secondary antibodies in 5% milk/TBS Tween buffers. The bands were then detected by the electrochemiluminescence by using the ECL kit (Amersham, La Jolla, CA) on standard X-ray film (Kodak X-Omat, Rochester, NY). Protein levels were measured by densitometric analysis using the Un-Scan-It gel software by Silk Scientific. Antibodies for Nox2 (ab 43801) and Nox4 (ab 60940) were from Abcam.
Statistical analysis. Data are shown as means Ϯ SE, and n is the number of blood vessels studied from different animals. Statistical significance between two groups was analyzed by using Student's 6 . The Nox4 inhibitor plumbagin decreases BPA superoxide and peroxide, even in the presence of Nox2 inhibition. A: superoxide detected by 5 M lucigenin is decreased in the presence of plumbagin (n ϭ 11 to 12). B: peroxide release from BPA detected by 10 M luminol plus horseradish peroxidase is also decreased in the presence of plumbagin (n ϭ 11 to 12). Superoxide is lowered even further when plumbagin is added to apocynin (Apo; C) and gp91-dstattreated BPA (gp91; n ϭ 11 to 12; D). t-tests within the same vessels. ANOVA were used for comparisons between multiple groups, and a Bonferroni's post hoc test was employed to determine significance between groups. A value of P Ͻ 0.05 was used to establish statistical significance.
RESULTS
Effect of Nox2 inhibition with apocynin and gp91-dstat on superoxide generation and the response of pulmonary arteries to KCl and hypoxia. To study the role of Nox oxidases in the response of pulmonary arteries to hypoxia, we initially exposed BPA rings to apocynin (100 M) and gp91-dstat (50 M). Since the Nox oxidases present in the endothelium-rubbed pulmonary arteries studied appear to be Nox2 and Nox4 (14) , these agents should function as inhibitors of Nox2. The data in Fig. 1 show that superoxide generation is significantly decreased in endothelium-removed BPA in the presence of apocynin and gp91-dstat. Since both agents decreased superoxide by similar amounts, they appear to be functioning through inhibiting Nox2 and not via antioxidant effects that have been associated with apocynin. However, as seen in Fig. 2 , A and B, force development to 25 mM KCl in BPA is not affected in the presence of either apocynin or gp91-dstat. As also shown in Fig. 2 , C and D, hypoxic contraction in BPA is not affected in the presence of either apocynin or gp91-dstat. These data show that even though Nox2 is responsible for some superoxide generation, it is not involved in the response of pulmonary arteries to hypoxia.
Effect of Nox2 and Nox4 depletion with siRNA on superoxide generation and the response of pulmonary arteries to KCl and hypoxia. In this part of the study Nox2 and Nox4 siRNA were used to decrease expression of Nox2 and Nox4 oxidases in endothelium-removed BPA, and a scrambled sequence of siRNA was used as a control. The data in Fig. 3A show that BPA transfection with Nox2 siRNA significantly decreased Nox2 protein expression, whereas transfection with Nox4 and scrambled siRNA did not affect Nox2 protein levels. Data in Fig. 3B show that only Nox4 siRNA decreased Nox4 protein expression, whereas Nox2 and scrambled siRNA did not detectibly alter Nox4 expression. Depletion of either Nox2 or Nox4 resulted in a significant decrease in superoxide generation in BPA (see Fig. 4A ); however, 25 mM KCl contraction was not affected by any of the treatments (Fig. 4B) . The data in Fig. 4C show that transfection by Nox4 siRNA causes a significant decrease in hypoxic contraction in BPA, whereas Nox2 and scrambled siRNA do not alter the contraction to hypoxia. These data point toward Nox4 being the source for the superoxide-derived peroxide that may be responsible for the basal relaxation in BPA that is removed during hypoxia leading to HPV.
Effect of Nox4 inhibition with plumbagin on ROS generation and force development to KCl and hypoxia in BPA. An original tracing of force development from BPA in the presence and absence of plumbagin (10 M) , an agent demonstrated to inhibit Nox4 (11) , is shown in Fig. 5A . The basal force during the 1-h incubation is significantly increased in the presence of plumbagin compared with the untreated vessel as shown by summary data in Fig. 5B . However, the total force, which is a sum of basal force increase seen with plumbagin treatment and 20 mM KCl force, is not affected in the presence of plumbagin (Fig. 5C ). The summary data in Fig. 5D show that in the presence of plumbagin HPV is not only lost, but there is instead a relaxation to hypoxia. Due to concerns that the actions of plumbagin could be working through alternative mechanisms such as influencing prostaglandins, it was confirmed (n ϭ 10) that 10 M indomethacin did not influence any of the actions of plumbagin on vascular contractile function. To investigate the actions of plumbagin further we also measured superoxide and peroxide generation from BPA in the presence and absence of plumbagin. In the presence of plumbagin, lucigenin (Fig. 6A) and luminol (Fig. 6B) chemilumiFig. 7 . Effects of short-and long-term removal of endogenous peroxide by ebselen on the contraction of BPA to KCl and hypoxia. A: long-term treatment (45 min before passive tension, Ebselen-Prol) of BPA with 0.1 mM ebselen does not affect 30 mM KCl contraction. The force generated by 30 mM KCl before DMSO vehicle (control) and acute ebselen (control-Eb) treatments is also shown (n ϭ 11). B: summary data showing that contraction to 25 mM KCl is significantly increased on short-term (30 min) treatment with ebselen, whereas long-term treatment does not affect force generation elicited by 25 mM KCl (n ϭ 11). C: summary data showing that hypoxic contraction is decreased by both short-and long-term treatment of BPA with ebselen (n ϭ 11).
nescence are significantly reduced compared with untreated BPA, suggesting that this agent decreases both superoxide and peroxide. The data in Fig. 6 also show that plumbagin significantly decreases superoxide even when it is decreased by the presence of the Nox2 inhibitors apocynin (Fig. 6C ) or gp91-dstat (Fig. 6D) .
Previous studies from our laboratory (1) have shown that short-term removal of peroxide through 0.1 mM ebselen (35 min before exposure to hypoxia) causes an increase in force development to KCl and an attenuation of hypoxic contraction in BPA. However, in the current study removal of peroxide from Nox4 by using either siRNA or plumbagin did not result in an increase in KCl-mediated contraction even though the hypoxic contraction was significantly attenuated. Since other studies from our laboratory (13, 22) have shown that peroxide is responsible for activation of both relaxing and contractile mechanisms, we hypothesized that although relaxing mechanisms could be turned off by acutely removing peroxide, the contractile mechanisms may require prolonged lowering of peroxide levels for their reversal. To test this hypothesis, we conducted experiments to compare the effects of short-term (35 min before hypoxia) and long-term (beginning 45 min before exposing rings to passive tension) removal of peroxide with 0.1 mM ebselen. Interestingly, the initial contraction to 30 mM KCl (Fig. 7A ) BPA is not affected by long-term treatment with ebselen, presumably because of the relatively high levels of force developed on exposure to this dose of KCl. The summary data in Fig. 7B show that contraction to 25 mM KCl on short-term exposure to ebselen is significantly greater than untreated BPA rings, which is consistent with previous studies from our laboratory (1). Prolonged exposure to ebselen, on the other hand, does not result in any significant change in the magnitude of the contraction to 25 mM KCl compared with BPA, which were not treated with ebselen. Hypoxic contraction (Fig. 7C ) in BPA rings exposed to both short-and long-term exposure to ebselen is significantly reduced. Since the response to hypoxia is examined in endothelium-removed BPA (and not influenced by inhibiting nitric oxide biosynthesis under these conditions), the peroxynitrite scavenging activity of ebselen is presumably not contributing to the alterations in contractile responses that are observed. Thus the observed effects of ebselen may originate from short-term exposure removing a peroxide-dependent relaxing mechanism, whereas long-term depletion of peroxide by ebselen may attenuate a peroxide-regulated contractile mechanism not acutely reversed by hypoxia, in addition to the relaxing mechanism that is reversed by acute hypoxia.
Effect of Nox4 induction with TGF-␤1 on ROS generation and force development to KCl and hypoxia in BPA.
Since studies conducted by Sturrock et al. (23) have shown that TGF-␤1 induces Nox4, we organ-cultured BPA rings with TGF-␤1 to study the effects of increased Nox4 expression in this part of our study. The data in Fig. 8, A and B, show that 48 h of organ culture with 4 nM TGF-␤1 results in a significant increase in Nox4 expression. Superoxide generation is significantly increased in vessels treated with TGF-␤1 (Fig. 8C) , which is not reversed by the Nox2 inhibitor apocynin. TGF-␤1 also causes a significant increase in peroxide release (Fig. 8D) , and both the increase in superoxide and peroxide are reversed in the presence of the Nox4 inhibitor plumbagin. Therefore, the summary data in Fig. 8 are consistent with the increase in superoxide and peroxide induced by organ culture with TGF-␤1 originating from an induction of Nox4. The data in Fig. 9A show that the detection of peroxide release from BPA organ cultured in the absence and presence of TGF-␤1 is attenuated by scavenging intracellular peroxide with ebselen or extracellular peroxide with 1 M catalase. The Nox4-associated increase in peroxide seen in BPA cultured with TGF-␤1 is accompanied by a decrease in the force initially generated on exposure to 25 mM KCl (Fig. 9B) . When the precontracted Fig. 8 . Evidence that transforming growth factor (TGF)-␤1 increases superoxide and peroxide associated with elevated expression of Nox4. Typical Western blot (A) and summary data (B) showing that 4 nM TGF-␤1 treatment increased Nox4 expression significantly in BPA (n ϭ 11) are shown. C: summary data showing that superoxide generation is significantly increased on treatment with TGF-␤1 for 48 h. Plumbagin (10 M) reversed the superoxide increase in TGF-␤1-treated vessels, whereas 100 M apocynin had no effect (n ϭ 8). D: summary data showing that peroxide release is also increased by TGF-␤1 and plumbagin significantly decreased peroxide in TGF-␤1-treated vessels (n ϭ 4). arteries are exposed to hypoxia, an increase in the hypoxic contraction is observed in BPA cultured with TGF-␤1 (Fig.  9C) . These data suggest that TGF-␤1 is inducing Nox4, and increased peroxide levels generated by Nox4 are enhancing a basal relaxation, which when removed on exposure to hypoxia results in the detection of an increased contraction or HPV response in BPA.
The role of mitochondria in the response of pulmonary arteries to hypoxia. To examine the role of mitochondria in the response of pulmonary arteries to hypoxia, we studied the effects of antimycin (10 M) and rotenone (10 M) on superoxide generation and hypoxic force development in BPA. The data in Fig. 10 show that in the presence of mitochondrial electron transport inhibitors antimycin and rotenone, there is a significant decrease in superoxide detected by lucigenin chemiluminescence. In contrast, force development to 20 mM KCl in the presence of antimycin and rotenone is not significantly different from untreated vessels. These mitochondrial electron transport inhibitors did not significantly alter hypoxic force development compared with untreated BPA. Therefore, the data in this part of the study show that even though the mitochondrial electron transport chain may be a source for the generation of ROS, it does not affect the response to hypoxia in BPA. Fig. 9 . Evidence that peroxide generation associated with increases in Nox4 expression elicited by TGF-␤1 is associated with alterations in the response of BPA to hypoxia. A: peroxide release from BPA organ cultured in the absence and presence of 4 nM TGF-␤1 is attenuated by scavenging intracellular peroxide with ebselen and extracellular peroxide with 1 M catalase (n ϭ 4). Summary data show that treatment of BPA with 4 nM TGF-␤1 decreases force generated by 25 mM KCl (B) and increases the magnitude of the contraction to hypoxia (C). The presence of ebselen increases force generated by 25 mM KCl in the absence or presence of pretreatment with TGF-␤1, and ebselen markedly attenuates further contraction to hypoxia in both groups of organcultured arteries in a manner consistent with roles for changes in peroxide levels in the effects of TGF-␤1 and hypoxia (n ϭ 6). Fig. 10 . Effects of inhibitors of mitochondrial electron transport on the levels of BPA superoxide and the response to hypoxia. Summary data show that 10 M antimycin and 10 M rotenone cause a significant decrease in superoxide generation (A) but do not affect force generated by 20 mM KCl (B) or the magnitude of the contraction to hypoxia in BPA (n ϭ 6 -8; C).
DISCUSSION
Roles for Nox oxidases in the generation of ROS and HPV response of BPA.
Inhibition of Nox2 with apocynin or gp91-dstat reduced the level of superoxide generation detected by lucigenin chemiluminescence endothelium-removed BPA in a manner consistent with Nox2 functioning as a source for the basal generation of ROS in BPA. However, both apocynin and gp91-dstat did not affect the contraction in BPA to 25 mM KCl (Fig. 2, A and B) or the increase in force elicited by hypoxia (see Fig. 2, C and D) . Thus these data show that even though Nox2 may be a basal source for the generation of ROS in BPA, it does not influence the response to hypoxia.
Transfection of BPA with siRNA sequences for Nox2 and Nox4 significantly decreased expression of Nox2 and Nox4 protein, respectively, without affecting the expression of the other oxidase, and the scrambled sequence transfection did not affect expression of either oxidase. Data in Fig. 4A show that superoxide generation in BPA is decreased by the siRNA treatments used to lower Nox2 or Nox4. Although contraction to 25 mM KCl is not affected by these siRNA transfections (Fig. 4B) , the contraction to hypoxia is only decreased in BPA transfected with Nox4 siRNA and not altered by the knockdown of Nox2 with siRNA (see Fig. 4C ). Thus the attenuation Nox2 activity with siRNA has effects that are similar to the actions of apocynin and gp91-dstat shown in Figs. 1 and 2 , where Nox2 inhibition decreased superoxide generation but did not affect contraction to either 25 mM KCl or hypoxia. Thus Nox2 and Nox4 are both involved in the basal aerobic generation of ROS in BPA, but only decrease in Nox4 expression and ROS by siRNA for Nox4 was accompanied with attenuation in HPV.
We also used a plant-derived yellow pigment plumbagin that has been shown in other studies (11) to inhibit Nox4 to further examine the role of Nox4 in BPA function. Since the decrease in superoxide with plumbagin is greater compared with apocynin or gp91-dstat, and plumbagin also decreases superoxide levels further when combined with apocynin or gp91-dstat compared with either of the inhibitors alone (Fig. 6, C and D) , plumbagin appears to be inhibiting ROS generation by Nox4. Plumbagin caused a gradual increase in basal force (Fig. 5, A  and B) , compared with untreated BPA rings, reaching a plateau at 1 h presumably due to its ability to remove superoxide and peroxide generated by Nox4. However, since little is known regarding the vasoactive actions of plumbagin, this interpretation needs to be made with caution. Although the increase in force to 20 mM KCl on top of basal force was decreased by plumbagin compared with untreated rings exposed to 20 mM KCl, the total force developed (basal force plus 20-mM KCl contraction) was not different between plumbagin-treated and untreated BPA rings (Fig. 5C) . The hypoxic contraction normally seen in untreated BPA was reversed to relaxation (Fig.  5D ) under conditions where plumbagin causes marked decreases in superoxide and peroxide levels (Fig. 6, A and B) . This data also support the concept that Nox4 is the source of the ROS in BPA, which is removed under hypoxia resulting in a HPV. The hypoxia-elicited relaxation observed in the presence of plumbagin is not seen in BPA transfected with siRNA for Nox4. Although the origin of the relaxation to hypoxia seen in the presence of plumbagin is not known, it may originate from either a greater degree of Nox4 inhibition by this probe compared with its depletion by siRNA or from a secondary pharmacological action of plumbagin, which is not related to its Nox4 inhibitory actions.
It has been shown previously (23) that TGF-␤1 induces Nox4 and increases ROS production in human pulmonary artery smooth muscle cells. BPA rings cultured with TGF-␤1 for 48 h showed an increase in the expression of Nox4 (Fig. 8,  A and B) . TGF-␤1 also caused an increase in superoxide (Fig.  8C ) and peroxide levels (Fig. 8D ), which were reversed in the presence of plumbagin, whereas apocynin did not reverse the TGF-␤1-elicited increase in superoxide levels. Hence, TGF-␤1 causes an increase in Nox4 expression associated with an increase in superoxide and peroxide levels. Contraction to 25 mM KCl under aerobic conditions (see Fig. 9B ) was significantly decreased under conditions where TGF-␤1 increased the level of Nox4-derived peroxide. Since acute exposure to ebselen markedly increases force generated by BPA organ cultured with TGF-␤1 when they are contracted with 25 mM KCl, the increased levels of peroxide scavenged by ebselen appear to be promoting a greater degree of relaxation under aerobic conditions. Hypoxic force (Fig. 9C ) was significantly increased on treatment with TGF-␤1 through what appears to be due to removal of a bigger basal relaxation maintained by higher levels of peroxide derived from increased expression of Nox4, because contraction to hypoxia was markedly attenuated in the presence of ebselen. Thus increasing Nox4 expression with TGF-␤1 appears to result in elevated generation of peroxide, which causes enhanced basal relaxation under normoxia. The greater degree of peroxide-mediated basal relaxation is then removed under hypoxia, leading to detection of a bigger HPV response.
Although the literature often describes Nox4 as a source of peroxide generation, the siRNA, TGF-␤1, and plumbagin data provide distinct evidence for Nox4 generating superoxide in a manner that would result in peroxide generation. Our recently reported evidence suggests that there is an essential role of Cu,Zn-SOD activity in enabling the detection of peroxide needed for depression of force under aerobic conditions, which Fig. 11 . Summary model showing where data generated in the present study provide evidence for a hypothesized role for hypoxia modulating the generation of peroxide by Nox4 in a manner that controls a relaxing mechanism removed by acute exposure to hypoxia leading to a hypoxic pulmonary vasoconstriction (HPV) response. The model includes a hypothesized role for basal levels of peroxide generated by Nox4 controlling a force enhancing process needed for the HPV response, which is not reversed by acute hypoxia. This model also illustrates how hypothesized mechanisms such as peroxideelicited relaxation through activation of soluble guanylate cyclase (sGC) and increased cGMP protein kinase (PKG)-mediated signaling and peroxideelicited force enhancement through increased Rho kinase activity have properties of systems that could participate in the BPA response to hypoxia. is hypothesized to be removed by hypoxia (1) . Thus it is possible that superoxide is efficiently converted to peroxide within the subcellular regions containing Nox4 activity that are regulating vascular relaxation. This concept is also supported by our previous studies documenting how peroxide modulation by electron donor and electron acceptor scavengers of superoxide influences the BPA response to hypoxia (21) .
Influence of mitochondria on ROS generation and the HPV response of BPA. To study the mitochondria as a source of ROS in the pulmonary artery, we used antimycin and rotenone to inhibit electron transport at complex I and III, respectively. In the presence of both antimycin and rotenone, superoxide generation was significantly reduced in BPA, pointing toward mitochondria as potential sources for the generation of ROS (Fig. 10) . However, 20-mM KCl contraction and hypoxic contraction were not affected by both antimycin and rotenone in BPA (Fig. 10) . Although the decrease in ROS with rotenone and antimycin confirms observations reported in previous studies by Archer et al., Mehta et al., and Michelakis et al. (2, 16, 17, 18) , the changes in mitochondrial ROS observed were not associated with altered BPA contractile function or responses to hypoxia. Due to the differences observed across species, it is possible that mitochondria-derived ROS have a greater influence on signaling mechanisms contributing to the contractile response to hypoxia observed under the conditions examined. Interestingly, these mitochondrial electron transport inhibitors increase mitochondrial ROS in bovine coronary arteries and attenuate the relaxation to hypoxia observed in these arteries as a result of increased peroxide generation (12) . Therefore, mitochondria are indeed responsible for the generation of ROS in BPA in a manner similar to Nox2, but they do not appear to influence the response of BPA to hypoxia.
Potential detection of both relaxing and force enhancing mechanisms needed for the HPV response potentially controlled by peroxide generated by Nox4. Based on the hypothesis that Nox4 is required for a peroxide-mediated relaxing mechanism that is removed by hypoxia, the lack of an observed increase in KCl force in BPA transfected with siRNA for Nox4 suggests that Nox4-derived ROS may have additional roles, which remain to be defined. It is important to note that peroxide has been shown (13, 15, 22) to be responsible for activation of both relaxing and contractile mechanisms in our previous work, leading us to hypothesize that although relaxing mechanisms may be turned off acutely by hypoxia, attenuation of contractile mechanisms may require a prolonged lowering of peroxide levels. Data from the current study in Fig. 7A show that either short-or long-term removal of peroxide with ebselen does not significantly alter the relatively high levels of force generated when BPA are contracted with 30 mM KCl. However, the contraction to 25 mM KCl (Fig. 7B) is significantly increased in the presence of short-term removal of peroxide by a 35 min pretreatment of ebselen. Long-term removal of peroxide with ebselen (beginning 45 min before exposure to the initial passive stretch when BPA are set up for contractile studies) does not lead to any change in force development when BPA are subsequently contracted with 25 mM KCl. This shows that short-and long-term removal of peroxide may have different effects due to turning off of different mechanisms. Hypoxic contraction (Fig. 7C) is significantly attenuated in the presence of both short-and long-term removal of peroxide with ebselen. These experiments suggest that Nox4-derived peroxide activates both contractile and relaxing mechanisms in BPA. The acute exposure to hypoxia rapidly reverses the relaxing mechanism associated with increased force under aerobic conditions. In contrast, the prolonged lowering of peroxide by treatments such as siRNA for Nox4 or an extended exposure to ebselen also appears to remove a peroxide-activated contractile enhancing mechanism preventing the detection of increased force upon an acute removal of peroxide by hypoxia. Although the contractile mechanism hypothesized to be activated by Nox4 has not yet been identified, recent studies suggest Rho kinase is an important peroxide-activated force enhancing mechanism in pulmonary arteries, which is not reversed by acute exposure to hypoxia (10) .
Overall, the data in the present study suggest that even though both Nox2 and mitochondria may be sites for the generation of ROS, they do not seem to influence the response of BPA to hypoxia. In contrast, Nox4 appears to be a key source for the generation of ROS involved in maintaining a basal relaxation in BPA under normoxic conditions, and removal of this Nox4-derived ROS under hypoxia leads to HPV. In addition, the effects of prolonged decreases in Nox4 expression and peroxide by siRNA and ebselen treatments, respectively, on the HPV response suggest the possibility that peroxide generation by Nox4 may maintain a force-enhancing mechanism, which is not reversed by hypoxia. The rationale for evidence generated in the present study supporting these hypothesized concepts related to Nox4 is summarized in the model shown in Fig. 11 .
